HIV/AIDS Drug Resistance

Overview | News and Viewpoints | HIV/AIDS Mutations | Research

Overview

Recommendations for Using Drug Resistance Assays (PDF) (January 10, 2011)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo
Diagnostic, Monitoring and Resistance Laboratory Tests for HIV (June 2010)
To read PDF, click here.
From New York State Department of Health AIDS Institute
HIV Drug Resistance Mutations by Drug Class (PDF) (February 20, 2009)
From Stanford University
Primary Drug Resistance and Strategies for First-Line HIV Treatment (September 22, 2008)
From TheBodyPRO.com
HIV Resistance: Frequency, Testing, Mechanisms (PDF) (November/December 2007)
In Topics in HIV Medicine, from International AIDS Society-USA
HIV Drug Resistance Notes: Resistance Levels Conferred by Key Mutations (December 2004)
[Archived Article]
A class-by-class chart of drug resistance associated with specific HIV gene mutations, adapted from the Stanford HIV Drug Resistance Database.
To read PDF, click here.
In Infectious Diseases in Corrections Report, from Brown Medical School
Use of HIV Resistance Testing in Antiretroviral Therapy Decision Making (December 2004)
[Archived Article]
A clinical overview by Ian Frank, M.D.
To read PDF, click here.
In Infectious Diseases in Corrections Report, from Brown Medical School
Genotypic Testing for HIV-1 Drug Resistance (April 2004)
[Archived Article]
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite
Mechanisms of HIV Drug Resistance: A Primer (March 2004)
[Archived Article]
In PRN Notebook, from Physician's Resarch Network
Assays for Antiretroviral Resistance (June 2002)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite
Resistance Tests Currently in Use (Fall 2001)
[Archived Article]
To read PDF, click here.
In CRIA Update, from AIDS Community Research Initiative of America
Ask Dr. Jeff: HIV Genotype Resistance Testing (Summer 2001)
[Archived Article]
How can two resistance tests give different results?.
In STEP Perspective, from Seattle Treatment Education Project
The Buzz: The Importance of Sequencing in Treatment Options (May/June 2001)
[Archived Article]
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
HIV Drug Resistance and Resistance Testing (2001)
From AIDS Community Research Initiative of America

News & Viewpoints

"Urgent Action" Needed to Prevent Resistance to Antiretroviral Therapy (September 27, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
IRIN/PlusNews Reports on Rise of Drug-Resistant Strains of HIV in Africa (February 9, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Global Drug Distribution Programs One Factor in Hastening Drug Resistance, Report Says (June 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Canada: Fewer HIV Patients Becoming Drug-Resistant -- B.C. Study (January 26, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Study Raises Concerns About Drug-Resistant HIV (January 15, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
S. African Doctor Sees Drug-Resistant HIV (January 4, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
AP Series Examines Worldwide Impact of Drug Resistance (January 4, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Resistance to Thai-Made Antiretroviral GPO-vir (Lamivudine/Nevirapine/Stavudine) Sharply Increasing (July 19, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
One Is the Loneliest Number (January/February 2005)
[Archived Article]
The New York City "superbug": a look back at an alarm that fizzled.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Drug Resistance in U.S. Likeliest Among Whites, Gay Men, Partners of HAART Patients (June 8, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
First Case of Potential PI Cross-Resistance Reported After Lopinavir Failure (April 29, 2004)
[Archived Article]
From aidsmap.com
Resistance Still Possible Despite Perfect Adherence, Study Says (August 28, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Japan: Doctors Say Drug-Resistant HIV on Rise (August 7, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Drug-Resistant HIV Strains Found in One Out of Every 10 Newly Infected European Patients (July 16, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Warning Over Drug-Resistant HIV (June 20, 2003)
[Archived Article]
The unregulated supply of HIV drugs in the developing world threatens to accelerate the development of drug-resistant HIV strains.
From BBC News
New Not-for-Profit Organization Launched to Combat HIV Resistance (April 9, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Resistance Test Combines Phenotype and Genotype (November 23, 2001)
[Archived Article]
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News

UCLA-Engineered Stem Cells Seek Out and Kill HIV in Living Organisms

CROI 2012: New Version of Tenofovir May Be Safer and More Suppressive

An Answer to a Commonly Asked Question: Is Treatment 100% Effective in Preventing HIV Transmission?

Insomnia, Daytime Sleepiness Common Among HIVers, but Not Made More Likely by HIV or Meds, Study Suggests

Do We Really Need Primary Prophylaxis for OIs Anymore?

More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.